Key result
Prolonged past exposure to secondhand tobacco smoke in never-smokers was associated with significantly elevated plasma elastin degradation markers compared to unexposed controls (0.33 vs 0.26 ng/mL).
Why the study?
It was unknown whether elastin degradation marker levels remain elevated in persons with remote history of secondhand tobacco smoke exposure and whether those levels associate with reduced lung function.
Does remote prolonged exposure to secondhand tobacco smoke increase elastin degradation markers and reduce lung function in never-smokers?
Cross-Sectional (n=296)
Yes
Does remote prolonged exposure to secondhand tobacco smoke increase elastin degradation markers and reduce lung function in never-smokers?
Prolonged past exposure to secondhand smoke, even when remote, is associated with higher systemic elastin degradation markers and reduced lung function in never-smokers.
Remote SHS history may sustain elastin degradation tied to occult lung impairment; hypothesis-generating for EDM as biomarker, needs prospective validation.
Background Prolonged past exposure to secondhand tobacco smoke (SHS) in never-smokers is associated with occult obstructive lung disease and abnormal lung function, in particular reduced diffusing capacity. Previous studies have shown ongoing SHS exposure to be associated with increased elastin degradation markers (EDM) desmosine and isodesmosine. Research Question Are EDM levels elevated in persons with remote history of SHS exposure, and are those levels associated with reduced lung function? Study Design and Methods We measured the plasma levels of EDM from 193 never-smoking flight attendants with history of remote but prolonged SHS exposure in aircraft cabin and 103 nonsmoking flight attendants or sea-level control participants without history of cabin SHS exposure, and examined those levels versus their lung function with adjustment for covariates. The cabin SHS exposure was estimated based on airline employment history and dates of smoking ban enactment. EDM plasma levels were quantified by high-performance liquid chromatography and tandem mass spectrometry. Results The median [interquartile range; IQR] plasma EDM level for all participants was 0.30 [0.24 to 0.36] ng/mL with a total range of 0.16 to 0.65 ng/mL. Plasma EDM levels were elevated in those with history of exposure to cabin SHS compared to those not exposed (0.33±0.08 vs. 0.26±0.06 ng/mL; age- and sex-adjusted P<0.001). In those with history of cabin SHS-exposure, higher EDM levels were associated with lower diffusing capacity (parameter estimate (PE) [95%CI]=4.2 [0.4 to 8.0] %predicted decrease per 0.1 ng/mL increase in EDM; P=0.030). Furthermore, EDM levels were inversely associated with FEV 1 , FEV 1 /FVC, and FEF 25-75 (PE [95%CI]=5.8 [2.1 to 9.4], 4.0 [2.2 to 5.7], and 12.5 [5.8 to 19.2]% predicted decrease per 0.1 ng/mL increase in EDM, respectively) (P<0.001). Interpretation Prolonged past exposure to SHS, even when remote, is associated with higher systemic elastin degradation markers that in turn is associated with lower lung function and in particular reduced diffusing capacity.
No takes yet. Share an insight, caveat, or question.
Rakic et al. (2021) conducted a cross-sectional in Healthy never-smokers (n=296). Remote prolonged exposure to secondhand tobacco smoke (SHS) vs. No history of cabin SHS exposure was evaluated on Plasma levels of elastin degradation markers (desmosine and isodesmosine) (p=<0.001). Prolonged past exposure to secondhand tobacco smoke in never-smokers was associated with significantly elevated plasma elastin degradation markers compared to unexposed controls (0.33 vs 0.26 ng/mL).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: